"Other migraine treatments either temporarily prevent the symptoms or they may reduce the symptoms after the migraine headaches start, " says Bahman Guyuron, M.
Peter Kim, Merck's head of research and development, said on the company's conference call that the study for migraine prevention was "exploratory" and used a different dosing schedule than other telcagepant trials.